FREE Webinar

Thursday, April 11, 2019
2:30-4:00 PM, Eastern Time
Register Now

The solid tumor microenvironment (TME) poses many challenges for the immune system. Altered signaling pathways and metabolic constraints in combination with persistent antigen loads cause T-cell exhaustion, which in turn leads to tumor progression. Various strategies are currently in use and unde development to recover T-cell functionality in the TME. Using small-molecule blockades to enhance T-cell functionality is one avenue that researchers are exploring alongside other advanced adoptive cell therapies. To predict a patient’s response to a therapy and to optimize individual therapies, immune-cell profiling systems can be utilized for polyfunctional analysis. In this webinar brought to you by The Scientist, presented by IsoPlexis, strategies to improve T-cell function in the TME will be explored, and IsoPlexis’ Polyfunctional Strength Index (PSI) will be explained in relation to a range of TME immunotherapy challenges.

Topics to be covered:...

  • Improving T-cell functionality for adoptive T-cell therapy in metastatic colon cancer, using small-molecule strategies
  • Applying polyfunction to a range of solid tumor microenvironment challenges in immunotherapy

Register Now

Meet the Speakers:

Sruthi Ravindranathan, PhD
Post Doctoral Researcher, Waller Lab
Winship Cancer Institute of Emory University

Jon Chen, MS
Director of New Collaborations


Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?